BOJI CRO: Passed the GLP certification review and obtained the "Drug GLP Certification Certificate"

BOJI CRO announced that the company recently received a new "Drug GLP Certification" issued by the National Medical Products Administration, with the certificate number GLP039010219. The company successfully passed the GLP certification re-examination and obtained the "Drug GLP Certification," with a total of 8 certification qualifications. The specific institution conducting non-clinical safety evaluation research for drugs is BOJI CRO Technology Co., Ltd. Drug Evaluation Center, located at Building 62, Nanxiang 1st Road, Science City, Huangpu District, Guangzhou. The testing projects include single and repeated dose toxicity tests, reproductive toxicity tests, genetic toxicity tests, local toxicity tests, immunogenicity tests, safety pharmacology tests, and toxicokinetics tests. The certification conclusion states that the company meets the requirements of the quality management standards for non-clinical research of drugs, valid until January 22, 2030. This successful GLP certification re-examination is beneficial for the company to undertake non-clinical safety evaluation business externally and continuously strengthen its ability to provide one-stop services for new drug research and development to clients